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Abstract
Establishing causative links between protein functional domains and global gene regulation is critical for advancements in
genetics, biotechnology, disease treatment, and systems biology. This task is challenging for multifunctional proteins when
relying on traditional approaches such as gene deletions since they remove all domains simultaneously. Here, we describe a
novel approach to extract quantitative, causative links by modulating the expression of a dominant mutant allele to create a
function-specific competitive inhibition. Using the yeast histone acetyltransferase Gcn5p as a case study, we demonstrate
the utility of this approach and (1) find evidence that Gcn5p is more involved in cell-wide gene repression, instead of the
accepted gene activation associated with HATs, (2) identify previously unknown gene targets and interactions for Gcn5p-
based acetylation, (3) quantify the strength of some Gcn5p-DNA associations, (4) demonstrate that this approach can be
used to correctly identify canonical chromatin modifications, (5) establish the role of acetyltransferase activity on synthetic
lethal interactions, and (6) identify new functional classes of genes regulated by Gcn5p acetyltransferase activity—all six of
these major conclusions were unattainable by using standard gene knockout studies alone. We recommend that a graded
dominant mutant approach be utilized in conjunction with a traditional knockout to study multifunctional proteins and
generate higher-resolution data that more accurately probes protein domain function and influence.
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Introduction
Establishing high-resolution, causative mapping of specific
protein function and cell response is a critical facet underlying
success in genetics, systems biology, drug discovery, and molecular
biotechnology [1]. This task is challenging for multifunctional
proteins that contain diverse functionalities including protein and
DNA interactions and catalytic activity. These proteins play
critical roles in epigenetic modification, signaling cascades, and
transcriptional regulation. When relying upon commonly invoked
approaches (such as gene deletions), it is difficult to directly link
one particular function of these proteins (such as catalytic activity
or a specific protein-protein interaction) to downstream gene
regulation. The reason for this difficulty is that coarse modifica-
tions like knockouts remove the entire protein and thus all of its
functions, thereby creating an environment for non-natural
associations or activity compensations that confound data analysis.
In this regard, gene knockout studies probe cellular response and
compensation, not necessarily precise protein function. While
alternative strategies to gene deletion have been used [2,3,4,5,6,7],
all of these methods result in pleiotropic effects that do not
specifically isolate the multiple functionalities inherent in proteins.
Here, we demonstrate the capacity of a unique, graded dominant
mutant approach to enable the systems biology study of a yeast
histone acetyltransferase.
The yeast histone acetyltransferase (HAT), Gcn5p, is a
multifunctional protein with catalytic and binding domains
(including Ada2 interaction and a bromodomain). A causative
study of acetyltransferase activity thus requires a removal or
reduction of catalytic function while maintaining native protein
interactions. HAT proteins are important targets of genetic studies
since they are critical for establishing acetylation of histones, which
have long been recognized as a mark of euchromatin and an
important activating genomic modification [8,9]. The yeast gene,
GCN5, encodes a histone acetyltransferase that serves as a well-
studied prototype [10,11,12] for transcription-associated HAT
activity. Gcn5p has a known crystal structure [13] and direct
homologues in higher eukaryotic systems. Only a small number of
Gcn5p putative gene targets have been identified even though it is
presumed that this HAT globally controls gene expression [14].
Moreover, as this HAT is nonessential like many epigenetic
factors, inherent protein redundancy implies that other HAT
proteins may compensate for Gcn5p in its absence and thus
confound data relying on knockout studies alone.
Some attempts have been made to specifically inhibit catalytic
activity of similar epigenetic proteins through inhibitors including
nucleotide analogues [15,16] and other small molecules
[17,18,19,20]. However, inhibitors are difficult to design de novo,
lack single target specificity, are limited in their concentration
ranges, and often have a lower than anticipated response rate [17].
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e36193Classically, dominant mutations have been widely used to probe
gene function, [21] improve tolerances and drug resistances,
[22,23,24] characterize disease states, [25,26,27,28] and map
protein functional domains [29]. In this regard, small point
mutations can abolish a particular function in isolation without
disrupting other protein activities. Here, we exploit the inhibitory
nature of dominant mutations and demonstrate that varying the
expression level of a non-catalytic dominant mutant in the
presence of the native, wild-type allele can specifically isolate
and titer the catalytic activity of the wild type protein.
Despite the common use of dominant mutants, no prior study
has paired these alleles with a promoter library to specifically and
quantitatively grade an isolated protein function and collect
systems level information. Here we demonstrate the power of a
graded dominant mutant approach to isolate and causatively study
the histone acetyltransferase catalytic activity of Gcn5p protein in
the yeast Saccharomyces cerevisiae and in doing so, uncover previously
unknown gene targets and functions of Gcn5p.
Results
gcn5-F221A competitively inhibits the catalytic function
of Gcn5p in a dose-responsive manner
We first sought to study the influence of Gcn5p-based
acetylation using a dominant mutant allele, gcn5-F221A, based
on prior evidence of absent in vitro acetylation activity [30]. We
observed that this allele failed to complement a BY4741 gcn5 null
strain in vivo (Figure S1) and determined it to possess no changes
to Gibbs Free energy using Protein Interfaces, Surfaces and
Assemblies [31], indicating a conservation of protein structure.
Alongside these tests, a second catalytically inactive, dominant
mutant (gcn5-E173A) was likewise constructed and tested (Dis-
cussion S1). This second mutant also competitively inhibited
native Gcn5p acetyltransferase activity.
In order to create quantitative, graded expression of these
dominant alleles, expression (and thus level of competitive
inhibition) was modulated through the use of a promoter library.
Expression of the mutant allele was established by cloning gcn5-
F221A into centromeric yeast expression vectors under the control
of a collection of mutant TEF-based promoters with previously
established expression capacities [32,33]. This library resulted in a
ratio of mutant to wild-type expression ranging from 2.5 fold with
the weakest promoter to 8–10 fold with the strongest promoter
(Fig. S2). Three genetic tests were used to establish and validate
the gradation and competition of catalytic activity by this mutant.
The first test involved the HIS3 locus, a known acetylation
target for Gcn5p [34]. Gene activation of HIS3 by Gcn5p-based
acetylation enables higher tolerance to a histidine analogue, 3-
aminotriazole (3-AT). In a gcn5D strain, HIS3 expression is
decreased, leading to amino acid starvation in the presence of 3-
AT and decreased cell growth. Each expression cassette
controlling gcn5-F221A was transformed into S. cerevisiae S288C
and growth rate was evaluated in the presence of 3-AT (Fig. 1a).
Strains with low expression of the mutant allele most-closely
resembled the wild-type strain, whereas at higher expression levels,
strains resembled that of the gcn5 null strain. Transcription of HIS3
was found to decrease in a manner that followed a competitive
inhibition curve (Fig. 1b). This data provides strong evidence that
the gcn5-F221A allele competes for Gcn5p acetylation sites in the
HIS3 promoter region and effectively decreases HIS3 transcrip-
tion. While the growth rate trend (Fig. 1a) shows a clear
correlation between mutant expression and growth rate, the trend
is linear rather than an inhibition curve. We believe this arises
from the more indirect measurement of growth rate, which is
impacted by many cellular and environmental factors, and
therefore integrates multiple signals, not just HIS3 expression
levels. By comparison, the measurement of HIS3 mRNA levels
(Fig. 1b) is a more direct measurement and thus presents the
more expected competitive inhibition curve.
A second test involved inhibiting the well-characterized Gcn5p-
based regulation of the Pho5 promoter [35,36,37]. This test was
conducted in two pho80 knockout strains of yeast, a haploid
(BY4741) and diploid (BY4743), as this mutation results in a
constitutively active Pho5 promoter [36]. Both hosts contained an
episomal synthetic gene circuit with the Pho5 promoter regulating
Figure 1. gcn5-F221A can impart a graded phenotype as
detected by histidine starvation assays. The gcn5-F221A mutant
was expressed in S288C with varying promoter strengths, and
starvation response measured via growth rate in minimal media
supplemented with 3.75 mM 3-aminotriazole. a. Growth rates of strains
harboring gcn5-F211A (#) were compared to wild-type (m) and gcn5D
strains (&). Error bars represent the standard deviation of biological
triplicates. Increasing the expression level of gcn5-F221A (through
progressively stronger promoters) results in a decrease in growth rate
approaching the value of the knockout strain. b. HIS3 mRNA levels were
measured for select promoter strengths (.07, .32, .68 and .95) using RT-
PCR. As gcn5-F221A promoter strength increases, HIS3 expression
decreases following a competitive inhibition pattern. These results
demonstrate that gcn5-F221A can exhibit a graded, competitive
phenotype at HIS3 as measured by starvation response.
doi:10.1371/journal.pone.0036193.g001
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the Pho5 promoter was assayed in yeast strains harboring the
collection of plasmids with graded gcn5-F221A expression (Fig. 2a,
b). The fluorescent signal decreases with the expression level of
gcn5-F221A, consistent with the hypothesis that this mutant allele
directly competes with the native Gcn5p protein. We found that
mean fluorescence followed a competitive inhibition model, where
increased expression of the dominant mutant decreased the mean
fluorescence.
We were able to fit our data to the Hill-slope competitive
inhibition model:
signal~Bottomz
Top{Bottom
1z10PS{log(IC50)
where Top is the signal strength in the absence of competition,
Bottom is the signal strength of a competitively saturated system and
IC50, or 50% effective concentration, occurs when the signal
strength is reduced to the value halfway between the upper and
lower bounds. The signal is a measure of average fluorescence in
RFU and PS is the relative promoter strength of the dominant
mutant. A best-fit was determined using a sum of least squares
regression with the experimentally determined values. These
models demonstrate that increased promoter strength is required
to inhibit the two chromosomal copies of GCN5 in a diploid strain
(curve shown in Fig. 2a and b). Results of the IC50 values are
found in Fig. 2c. Finally, yECitrine mRNA levels decreased as a
function of gcn5-F221A expression (Fig. 2d). This test demon-
strates the ability of a dominant mutant allele approach to make a
direct measurement relating the grading of acetyltransferase
activity to downstream gene expression (in this case, Gcn5p
acetyltransferase activity and Pho5 promoter activity).
gcn5-F221A competitively inhibits global histone
acetylation at H3K18
In a third test, we sought to demonstrate that the graded
dominant mutant, gcn5-F221A, was directly impacting histone
acetylation. In S. cerevisiae, lysine 18 of histone 3 is primarily
acetylated by Gcn5p, with very little acetylation occurring in a
gcn5D strain [38]. An immunofluorescence assay for acetylated
H3K18 residues was conducted using mid-exponential phase,
fixed yeast cells. Three promoter strengths (0.32, 0.68, and 0.95
relative to wild-type TEF) were used to drive the expression of
gcn5-F221A and these strains were compared to wild-type and
gcn5D strains. Additionally, two further controls (over-expression of
wild type GCN5 and graded expression of a catalytically active
mutant allele, gcn5-M193A) were used to demonstrate the specific
acetylation inhibition only afforded by gcn5-F221A. Neither the
wild-type GCN5 nor the catalytically active mutant gcn5-M193A
showed a change in global H3K18ac. By comparison, expression
of the inactive, dominant mutants, gcn5-F221A, resulted in a dose-
dependent decrease of H3K18 acetylation. These results, illus-
trated in Fig. 3a and quantified in Fig. 3b, demonstrate that
gcn5-F221A competes directly with native Gcn5p, resulting in
reduced histone acetylation. The second catalytically inactive,
dominant mutant (gcn5-E173A) showed a similar direct impact on
global H3K18ac (Discussion S1).
Combining expression profiling with a graded dominant
mutant approach reveals novel Gcn5p targets and function
Next, we sought to evaluate the global influence of Gcn5p
acetyltransferase activity on yeast gene expression. By using our
approach, genes whose expression changes as a function of gcn5-
F221A level are changing as a result of decreased acetyltransferase
activity. Using microarrays, we identified and classified differen-
tially expressed genes between S. cerevisiae (S288C) wild-type, the
gcn5 null strain, and mutant gcn5-F221A expressed at three
different promoter strengths (0.32, 0.68 and 0.95) (Table S1). A
total of 282 genes were found to be differentially expressed (p-
value,0.05, abs(log2).1) between the wild-type and knockout
strain. This dataset overlaps a similar previously reported gene
expression study for gcn5D with 98% coverage [39]. A total of 288
genes were found to be differentially graded in response to gcn5-
F221A (i.e. genes whose expression changes monotonically in
response to gcn5-F221A and all of which had p-values,0.05).
Despite these similar numbers, only 153 genes (53%) found in the
knockout data set overlap with the graded dominant mutant
dataset (Fig. 4c). This initial analysis indicates that, for
multifunctional proteins, classifying genes and regulation based
exclusively on knockout data is misleading. Of the 288 genes
influenced by gcn5-F221A, 66% increased in expression in response
to increasing gcn5-F221A levels (Fig. 4a) whereas the gcn5 null
strain significantly overestimates the number of under-expressed
genes (Fig. 4b). This data set augments our knowledge of gene
targets regulated by Gcn5p-acetyltransferase activity.
Four non-mutually exclusive classifications of gene expression
were used to characterize the targets found in this study—
catalytically associated, non-catalytically associated, false negatives
(compared to a knockout), and opposites—by comparing these gene
targets to data obtained using the traditional knockout approach. A
subset of Gcn5p-impacted genes illustrates these trends (Fig. 5).
The 288 genes identified through gcn5-F221A inhibition of native
Gcn5p acetylation display a ‘graded’ response and are therefore
associated with Gcn5p catalytic activity. Within this classification,
variations in the response to level of gradation exist. Some genes
(such as ETR1 and YLR211C, Fig. 5a) achieve maximal gradation
(a plateaued response matching that of a knockout condition) at low
levels of gcn5-F221A. We posit that similarly responding genes (with
low grading thresholds) are strongly impacted by Gcn5p acetylation
and potentially have the fewest redundant epigenetic modification
mechanisms in yeast. In contrast, genes that require higher levels of
the dominant mutant to achieve maximal gradation (such as IDH2
and RRT5, Fig. 5a) are less sensitive to acetylation by Gcn5p or
have moreredundant regulation mechanisms.Thisapproachallows
for an evaluation of gene thresholding responses, an important
concept in systems biology modeling.
We observed 129 ‘non-catalytically associated’ genes in this data
set (genes differentially expressed in the knockout strain, but not
significantly impacted in response to the graded dominant mutant)
(Fig. 5b). Since gcn5-F221A only inhibits acetyltransferease
activity, we hypothesize that these non-catalytically associated
genes are not influenced by Gcn5p acetylation activity, but instead
are influenced by another indirect effect of Gcn5p, such as protein
complex association. Furthermore, we observed that 36 (12.5%) of
those genes impacted by the dominant mutant showed no change
in expression between the wild-type and knockout strains (Fig. 4c,
5c). These ‘false negatives’ are clearly impacted by Gcn5p activity,
and we hypothesize that these genomic loci are directly acetylated
by Gcn5p, but in its absence, another HAT with redundant
functionality steps in.
Finally, we observed that 44 genes (15%) impacted by the
dominant mutant display an ‘opposite’ effect in expression as
predicted by the gene knockout (Fig. 4c, 5d). In the majority of
these cases, these genes were over-expressed in response to gcn5-
F221A but significantly decreased in expression in the gcn5D strain.
The impact of these various gene classes was further evaluated
using RT-PCR for select genes exhibiting a graded response. We
Quantitative, Graded Dominant Mutant Approach
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quantitative, high-resolution measurement of the impact of Gcn5p
catalytic activity (Discussion S2). Additional control samples
were used to demonstrate that these genes had altered expression
as a result of gcn5-F221A only, and not in the presence of over-
expressed GCN5, which at the genetic level behaved the same as
wild-type yeast (Fig. S3). Moreover, these higher-resolution
datasets linking catalytic activity and gene regulation enable a
more precise measurement of thresholding effects.
Finally, we sought to determine what, if any, impact varying
expression of mutant Gcn5p had on the expression of native
Gcn5p. A p415-pGcn5-yECitrine plasmid was constructed, with
both a short and long GCN5 promoter, and co-transformed with
the p416-TEFx-gcn5-F221A plasmid collection. In this system,
fluorescent protein expression is controlled by the GCN5 promoter,
thus this construct serves as a promoter-based transcription
reporter. Using mid-exponential, biological triplicates and flow
cytometry, we measured fluorescent levels across the full range of
mutant gcn5-F221A expression. Regardless of promoter strength
driving mutant gcn5-F221A, we observed no change in fluorescent
expression (Fig. S4). This result indicates that expression of gcn5-
F221A does not create artificial feedback or perturbations of native
GCN5 expression. Thus, these results demonstrate the clear link
between the data we observe and the lack of catalytic function
inherent in gcn5-F221A.
Histone modifications are accurately uncovered using a
graded dominant mutant approach
We next sought to see whether specific chromatin modifications
can be deduced from microarray data alone when using a graded
dominant mutant approach. To do so, genes identified in our
microarray study were analyzed using Chromatin DB [40]
(Discussion S3). Using genes identified by a gcn5D knockout
(including subclasses of up-regulated, down-regulated, and differ-
entially expressed), no significant enrichment or depletion of
chromatin lysine acetylation is evident. This same lack of
enrichment or depletion is observed using the microarray data
obtained by a separate and independent gcn5D study [39].
However, by examining the graded up genes with low grading
thresholds identified in this study, significant depletion is seen in
H2BK11ac, H2BK16ac, H3K18ac, H3K14ac, and H3K23ac
with p-values of less than 10
23 to 10
24. This profile of histone
modifications mimics those observed in a Gcn5p binding study
[11]. Furthermore, the ‘false negative’ gene set exhibits acetylation
depletions for the same lysine residues as genes that are graded up.
This clearly demonstrates that ‘false negative’ genes are indeed
direct targets of Gcn5p acetylation and explains why the vast
majority of these ‘false negative’ genes increase in expression in
response to gcn5-F221A. In contrast, the non-catalytically associ-
ated data set exhibits no enrichment or depletion of chromatin
lysine modifications. In the case of those genes exhibiting an
‘opposite’ response, the primary histone modification that is
observed is a depletion of H4K16ac (p-value ,10
23). It is well
known that Sir2p and Esa1p are responsible for targeting H4K16
[41], which implicate the actions of these proteins as potential
compensators for Gcn5p. Collectively, these results demonstrate
that the graded dominant mutant approach can identify the
canonical acetylation targets of Gcn5p [42].
Gene ontology analysis reveals new cellular processes
that are impacted by Gcn5p acetylation
Gene ontology and network analysis tools were used to further
classify the genes influenced by gcn5-F221A activity and evaluate
the dataset (Discussion S4). Three functional classes (nucleolus,
ribosome biogenesis, and RNA metabolic processes) were
significantly enriched in the set of genes exhibiting an under-
expression graded response. Nearly 70% of the genes exhibiting
under-expression were associated with these functional classes.
Furthermore, one gene ontology class (oxidoreductase activity) was
overrepresented in genes exhibiting an over-expression in a graded
fashion, and is thus a target for Gcn5p-based gene repression. This
analysis expands the role of Gcn5p activity to other fundamental
cellular processes.
Graded dominant mutant approach can interface with
other phenotypic and genetic assays
Finally, we sought to demonstrate how the graded dominant
mutant approach can be used in conjunction with phenotypic and
genetic assays. Prior to this work, it was unclear whether
acetylation or protein-protein interaction is the root cause of
gcn5D synthetic lethal genes. To address this issue, we paired a
gene deletion with various promoter strengths driving gcn5-F221A
to simulate the lethal double knockout strain in the haploid yeast
BY4741. Twenty two of these synthetic lethal genes were selected
for this study and evaluated (Table I, Table S2). Only three gene
knockouts, Dccr4, Drsc2 and Drtt109, were highly impacted in a
graded fashion by the dominant mutant. Drtt109, a HAT known to
acetylate H3K56 and H3K9 [43], demonstrated the most
significant impact. Fifteen of the gene deletions were moderately
impacted and four showed almost no change. Collectively, these
results implicate the relative importance of Gcn5p’s catalytic
activity versus its protein and DNA interactions. As a comparison,
ten BY4741 null strains were selected at random to serve as a
control group (Table S2). None of these strains showed a growth-
rate dependent response to the gcn5-F221A mutant, indicating the
significance of the results described above.
Finally, we sought to investigate the global impact of Gcn5p
acetyltransferase activity on cellular phenotypes. To do so, we
evaluated the impact that grading this activity has on the basis of
documented large-scale chemical tolerance assays of null mutants.
Yeast strains with a gcn5 null allele have previously been shown to
have increased sensitivity to cycloheximide [44], ethanol [44], 5-
fluorouracil [45], KCl [46], MnCl2 [46], CaCl2 [46], and
sulfanilamide [47]. Growth inhibition assays were performed
using strains containing gradations of the dominant mutant, as
well as a wild-type control and a Dgcn5 control, as described in the
Materials and Methods.
When treating the strains with cycloheximide, we observed a
graded, linear decrease in growth rate that coincided with
increasing gcn5-F221A expression, showing that cycloheximide
Figure 2. Evaluating competitive inhibition by gcn5-F221A using a synthetic pPHO5-yECitrine construct. The gcn5-F221A mutant was
expressed with varying promoter strengths in a. the haploid BY4741 pho80D and b. the diploid BY4743 pho80D, and co-expressed with a second
plasmid, containing the yECitrine gene driven by pPho5. Average fluorescence in mid-exponential phase are reported and error bars represent
standard deviations of biological triplicates. Increasing expression of gcn5-F221A resulted in decreased mean fluorescence. The data was fit to a Hill-
slope competitive inhibition model (dashed line) and IC50 values were extracted (c), indicating the relative promoter strength of gcn5-F221A resulting
in half-maximal inhibition. Diploid yeast required nearly twice as strong promoter strength. d. yEcitrine mRNA levels were measured using RT-PCR for
select promoter strengths (.07, .16, .32, and .70). The gcn5-F221A mutant serves as a competitive inhibitor to wild-type GCN5 acetyltransferase activity.
doi:10.1371/journal.pone.0036193.g002
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e36193Figure 3. Global acetylation at H3K18 is attenuated by expression of mutant gcn5-F221A. Using immunofluorescence, H3K18 acetylation
was assayed globally for strains harboring the gcn5-F221A mutant (#) expressed with varying promoter strengths (.32, .68, and .95). For comparison,
gcn5-M193A mutant (N) (fully functional) with the same promoter strengths, along with wild-type (m), gcn5D (&) and wild-type with GCN5 (D) over-
expressed, were also examined. The primary antibody targets H3K18ac and the secondary antibody is an IgG tagged with DyLight 649. Cells were
stained with DAPI to visualize nuclear material. a. Cells were imaged with both DAPI and Cy5 filters. The gcn5-F221A mutant results in global
attenuation of H3K18ac and approaches gcn5D strain at high strength promoters. By comparison, the gcn5-M193A mutant and wild-type with GCN5
result in no change to acetylation levels. b. Average cell intensity was quantified using Metamorph software and normalized relative to the wild-type.
doi:10.1371/journal.pone.0036193.g003
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S5). Assays performed using ethanol, 5-fluorouracil, KCl, 4mM
MnCl2, and 8 mM MnCl2 as a growth inhibitor did not exhibit
this trend (Table S3). These growth inhibitors are akin to the
non-catalytically associated gene expression data set, and we
hypothesize that increased sensitivity to these growth inhibitors is
not a result of decreasing cellular Gcn5p acetylation, but by a
separate, indirect effect. Despite prior reports, sulfanilamide,
CaCl2, and 40 mM MnCl2 inhibitors did not impact growth rate
for any of the strains in our liquid-culture based experiment.
Discussion
Using a graded dominant mutant approach and Gcn5p as a
case study, we are able to determine global gene targets and
impacts, and to extract the causative linkage between the catalytic
domain of Gcn5p and gene regulation. In particular, we (1) find
evidence that Gcn5p is more involved in cell-wide gene repression,
instead of the accepted gene activation associated with HATs, (2)
identify previously unknown gene targets and interactions for
Gcn5p-based acetylation, (3) quantify the strength of some Gcn5p-
DNA associations, (4) demonstrate that this approach can be used
to correctly identify canonical chromatin modifications, (5)
establish the role of acetyltransferase activity on synthetic lethal
interactions, and (6) identify new functional classes of genes
regulated by Gcn5p acetyltransferase activity—all six of these
major conclusions were unattainable by using standard gene
knockout studies alone. These results demonstrate the power of the
graded dominant mutant approach, which unlike traditional
methods, only impacts one particular facet of the querying protein
(in this case, acetyltransferase activity) and is therefore especially
useful for studying multifunctional proteins and global regulators.
Despite the common conception that Gcn5p-based acetylation is
gene activating, we posit that Gcn5p-based acetylation serves a
Figure 4. Expression analysis comparing a graded dominant mutant of gcn5-F221A to gcn5D. Microarray analysis was conducted for
strains expressing the gcn5-F221A mutant at varying promoter strengths (.32, .68, and .95) along with wild-type and gcn5D cells. a. Of the genes
found to be up-regulated compared to the wild-type, only 84 were commonly identified by both the dominant mutant and knockout, and 107 were
only identified by the dominant mutant. b. Significantly fewer genes were found to be down-regulated, of which only 69 were commonly identified
and 28 were only identified by the dominant mutant. c. Characterization of the 288 genes observed to exhibit a graded response with respect to
increasing levels of gcn5-F221A.
doi:10.1371/journal.pone.0036193.g004
Figure 5. Gene expression heat maps for select genes illustrat-
ing unique traits in this study. Four key (non-mutually exclusive)
trends in gene expression were observed in this study: catalytically
associated genes, false negatives (compared to a knockout), non-
catalytically associated genes, and opposites. In the heat map, red
indicates underexpression, and green overexpression relative to the
control, and the size of the dot is proportional to magnitude of
expression. A select sample of genes was used to display the four trends.
a. Catalytically associated genes have expression that changes (either up
or down compared to control) as a function of gcn5-F221A. The threshold
for response varies for each of these genes. b. 129 non-catalytically
associated genes (changed in gcn5D, but not graded by gcn5-F221A)
were identified, suggesting these targets are not impacted by Gcn5p
acetylation, but perhaps by another indirect effect of Gcn5p such as
proteincomplexassociation.c.36falsenegativegeneswereidentified,in
which expression is graded by the dominant mutant, but are unchanged
in the knockout strain. These genomic loci are most likely directly
acetylated preferentially by Gcn5p along with other compensatory HATs.
d. An additional set of 44 genes demonstrate an opposite effect in the
presence of the dominant mutant compared to the gcn5D.
doi:10.1371/journal.pone.0036193.g005
Table 1. Impact of gcn5-F221A on the growth rate of GCN5
synthetic lethal genes.
GCN5 synthetic lethal Influence of acetyltransferase activity
ccr4
rtt109
rsc2
Highly Impacted
eaf7
hhf2
hht2
hsl1
hsl7
leu2
mot2
nam2
not5
paa1
pap2
rad6
rpd3
sin3
snf2
Moderately Impacted
elp3
iki3
pho23
spt20
Not Impacted
We examined 22 gene knockouts with known synthetic lethal interactions to
gcn5 null. The gcn5-F221A dominant mutant was expressed at varying levels in
the background of a knockout strain and growth rate was measured (Table
S2). Three gene knockouts, Dccr4, Drsc2,a n dDrtt109, are highly impacted by
the gcn5-F221A mutant and exhibited a more than a 20% reduction in growth
rate when the gcn5-F221A mutant was highly expressed, indicating these
synthetic lethal pairings are highly dependent on Gcn5p catalytic activity. The
majority of the genes show a moderate decrease in growth rate as mutant
expression is increased while several showed no growth rate changes. Most of
these synthetic lethal interactions are not impacted by catalytic activity, but
rather require Gcn5p for a protein-protein or protein-DNA interaction. Ten gene
deletions were randomly selected as a control and none exhibit any response
(Table S2).
doi:10.1371/journal.pone.0036193.t001
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found that over-expression of a catalytically inactive dominant
mutant led to up regulation of 66% of affected genes. This finding is
unexpected and not evident from traditional knockout experiments,
as gene expression changes in the knockout strain were equally
distributed between over and under expression. This is the first time
that Gcn5p-based acetylation has been implicated with global gene
repression, and may be a direct function of Gcn5p or an indirect
result of additional gene regulators that are controlled by Gcn5p.
Our global microarray study identifies a set of 44 ‘opposite’
genes, whose expression in the presence of the catalytically inactive
dominant mutant is opposite that of expression in a gcn5D. Further
analysis of this set of genes indicates that nearly half are shown to
be associated with the SAGA complex in an independent study
[39]. It is likely that this ‘opposite’ phenomena is due to the
partitioning of Gcn5p function and targeting across the domains
(potentially the catalytic and bromodomains). In the case of the
graded dominant, targeting of the SAGA complex can still occur
and thus transcription is increased at these genes. However, in a
gene knockout, the entire Gcn5p transcriptional coactivator is
missing and thus transcription is impeded significantly. Under-
acetylated H4 histone proteins have also been shown to have a
biased association with SAGA-regulated genes [39], further
solidifying the SAGA-complex link to these opposite genes. These
results provides another example that removing a globally
functioning protein like Gcn5p results in an artificial genetic
background with misleading observations regarding true protein-
DNA interactions. Moreover, these results highlight how novel
hypotheses of function can be deduced from this approach.
Based on the results presented here, we would recommend that a
graded dominant mutant approach be utilized in conjunction with a
traditional gene knockout to study gene regulatory proteins,
especially those that serve multiple functions. The resulting data is
higher-resolution and more accurately defines protein domain
function and influence. While demonstrated here for the case of
acetyltransferase activity of the yeast protein Gcn5p, this approach
can theoretically be extended to other proteins and domains of
interest.Bycreating twodistinctGcn5pdominantmutantsthatcould
both be graded and competitively inhibit native Gcn5p, we
demonstrated that this approach is easily implemented. This
approach uniquely enables a systems biology view of the cell while
at the same time leveraging synthetic biology tools [48]. The
identification ofdominant mutationsthat can removesinglefunctions
are either well-documented for many proteins of interest or can be
identified with the proper genetic screens. Additionally, promoter
libraries with documented expression capacity are available for most
majormodel systems[32,49,50].Thus,thisapproach is generalizable
for other proteins in classes such as epigenetic modification, signaling
cascades, and transcriptional regulation as well as for essential genes,
which cannot be deleted, and this method is not necessarily restricted
to the yeast system studied here. In addition, this approach can be
combined with any cell state assay including, but not limited to, gene
expressionanalysis,phenotypicassays,geneticscreens,ChIPanalysis,
and metabolomics. In conclusion, the graded dominant mutant
approach is able to circumvent the problems seen in standard genetic
approaches and can provide a causative linkage between specific
protein function and phenotype.
Materials and Methods
Strains and Plasmids
Yeast expression vectors were propagated in Escherichia coli
DH10b (Table S4). All experiments were carried out in
Saccharomyces cerevisiae, with parent strains including BY4741,
BY4743, and S288C and their derivatives described in Tables
S4 and S5. The BY4741 knockout strains were provided by the
Marcotte laboratory (University of Texas at Austin, ICMB).
S288C and BY4743 homozygous Dpho80/Dpho80 strains were
purchased from OpenBiosystems. The S288C Dgcn5 strain was
made by replacing the wild-type GCN5 gene with a hygromycin-B
resistance gene amplified from plasmid pAG32 using primers 1
and 2 (Table S6) and extended using primers 3 and 4, for a final
fragment with 80 base pairs of genomic homology both upstream
and downstream. Using a high efficiency yeast transformation
protocol [51], 1 mg of fragment was transformed into competent
S288C cells and were plated on YPD supplemented with 100 mg/
mL hygromcyin-B. The genotype of the S288C Dgcn5 strain was
confirmed by extracting genomic DNA and performing both a
positive PCR control (primers 5–8) and a negative PCR control
(primers 9 and 10).
The wild-type GCN5 gene was amplified from BY4741 gDNA
using primers 9 and 10 and cloned into the pUC19 vector using
restrictions enzymes XbaI and SalI. After confirming the accuracy
of the GCN5 sequence, mutations M193A, F221A and E173A
were introduced using the Stratagene Quikchange mutagenesis kit
and primers 11 to 14, and 39 and 40. The mutant GCN5 genes, as
well as the wild-type gene, were cloned into the library of p416-
TEFmutant vectors [32] using the XbaI and SalI restriction
enzymes. The gcn5-M193A, F221A, and E173A plasmid collections
were transformed into BY4741 Dgcn5 using a Gietz lithium acetate
protocol [51] and selecting on drop out media deficient in uracil to
create strains AML1 through AML30 (Table S5).
To allow for expression in amino acid free media, the p416-
TEFmutant-gcn5-F221A plasmid collection was modified to include
a G418 resistance gene. Using primers 15 and 16, the gene was
amplified from the pUG6 plasmid. The p416-TEFmutant-gcn5-
F221A plasmid collection and the resistance gene were digested
with StuI and EcoRV. The new p416-TEFmutant-gcn5-F221A-
G418 plasmid collection was transformed into S288C using a
Gietz lithium acetate protocol and selected on YPD plates
supplemented with 200 mg/mL G418 to create strains AML31
through AML40 and AML227–228. This process was repeated to
create p416-TEFmutant-gcn5-E173A-G418 and p416-TEFmutant-
gcn5-M193A-G418 plasmid collections, and to create strains
AML229–247.
The p415-pPho5-yECitrine plasmid was constructed for
fluorescence assays. The PHO5 promoter, shown to be contained
in the thousand base pairs upstream of PHO [35], was amplified
using primers 17 and 18. Using restriction enzymes SacI and
XbaI, pPho5 was cloned into the p416-TEF-yECitrine vector,
replacing the TEF promoter in front of the yECitrine fluorescence
gene. Using SacI and KpnI, the pPho5-yECitrine fragment was
moved to the p415 plasmid, which contains a leucine auxotrophic
marker. Along with the p416-TEFmutant-GCN5 plasmid collections,
the p415-pPho5-yECitrine plasmid was transformed into BY4741
Dpho80 and BY4743 Dpho80 using a Gietz lithium acetate protocol
and selected on drop out media deficient in both uracil and leucine
to create strains AML51 through AML66. The p415-pGcn5-
yECitrine plasmid was constructed for fluorescence assays. The
GCN5 short promoter (350 bp) was amplified using primers 41 and
42, and the long (640 bp) promoter with primers 42 and 43
directly upstream from the GCN5 gene. Using SacI and XbaI, the
p415-pPho5-yECitrine plasmid was replaced with p415-pGcn5-
yECitrine, and then along with the p416-TEFmutant-GCN5 plasmid
collection, transformed into BY4741 Dpho80 using a Gietz lithium
acetate protocol and selected on drop out media deficient in both
uracil and leucine to create strains AML248 through AML261
(Table S5).
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genes that form a synthetic lethal phenotype with gcn5D, were
transformed with a p416-TEF control plasmid, and p416-
TEFmutant-gcn5-F221A plasmids with promoter strengths of 0.16,
0.32, 0.68 and 0.95. A Gietz lithium acetate protocol was used and
colonies were selected in triplicate from drop out media deficient
in uracil to create strains AML67 through AML176. An additional
ten BY4741 single gene knockouts, selected at random, were
transformed under identical conditions to serve as an experimental
control (AML177–226).
All strains listed above were selected and tested in biological
triplicate at minimum. Some strains and assays were tested with up
to 6 biological replicates.
Media and Growth Conditions
YPD media contains 20 g/L yeast extract, 10 g/L peptone and
10 g/L glucose. Minimal media for S288C strains contains 6.7 g/L
nitrogen base, 20 g/L glucose and 200 ug/mL G418. Minimal
media for BY4741 and BY4743 strains was supplemented with
amino acids; 0.77 g/L of CSM –Ura (MP Biomedicals) for p416
vectors and 0.67 g/L of CSM –Leu –Ura (MP Biomedicals) for
p416/p415 vectors. Media M-gYG418 contained 20 g/L glucose,
6.7 g/L YNB, and 200 mg/mL antibiotic G418. Bacteria were
grown in lysogeny broth with ampicillin. All yeast strains were
grown at 30uC and bacteria at 37uC. Agar plates were grown in
standing incubators and cultures in shakers operating at 225 rpm.
Passage numbers for yeast cultures were kept low (2–3) for all
experiments.
Growth Experiments
Complementation studies were conducted using strains AML1-
AML30 and AML228–241. From stationary phase culture, a
honey-comb plate was inoculated in triplicate with a starting OD
of 0.1. Minimal media lacking uracil was supplemented with 3-
aminotriazole. Using a Bioscreen C Growth Curve Analysis
System, optical density measurements were taken every ten
minutes for 24 hours. Temperature was maintained at 30uC and
continuous, high shaking was used. Growth rate was calculated as
the slope of the natural log of optical density versus time during the
exponential growth phase. The histidine starvation assay was
conducted using strains AML31 through AML40. From stationary
phase culture, a honey-comb plate was inoculated with 4–6
biological replicates with a starting OD of 0.1. A minimal media
composed of glucose, yeast nitrogen base without amino acids,
3.75 mM 3-aminotriazole and 200 ug/mL G418 was used. S288C
wild-type and S288C Dgcn5, both transformed with an empty
p416-TEF-G418 plasmid, served as controls. Optical density
measurements were collected over a period of 30 hours using a
Bioscreen C and settings described previously.
Ten additional growth inhibition assays were conducted, in
which a total of 50 strains were assayed, including the above
controls, and 4–5 biological replicates of strains AML31 through
AML40. The 50 strains were grown to stationary phase in 3 mL of
M-gYG418 and then a honey-comb plate was inoculated with a
starting OD600 of 0.1 in 250 ml fresh M-gYG418 either with or
without (control cultures) a putative Gcn5p-dependent growth
inhibition additive (Table S3). Optical density measurements
were collected for the 100 cultures over a period of 60 hours using
the Bioscreen C.
Fluorescence Assays
Fluorescence assays were conducted using strains AML41
through AML66. 4–6 biological replicates were grown in drop
out media lacking uracil and leucine until stationary phase. Fresh
cultures were seeded at a low starting optical density (approxi-
mately 0.005) and allowed to grow to early exponential phase. The
cell mass was collected by centrifugation and re-suspended in ice
cold water. Fluorescent expression profiles were determined using
a FACS Calibur and compared to a control population. Forward
scattering had a voltage setting of E00 and ampgain of 2.96, side
scattering a voltage of 505 and ampgain of 1.00 and fluorescence a
voltage of 551 and ampgain of 1.00. Forward and side scattering
data were linear and fluorescence was collected on a logarithmic
scale. Threshold was set to a forward scattering value of 52. An
average fluorescence and standard deviation was calculated from
the mean values for the biological replicates. The competitive
binding curve was determined for both the haploid and diploid by
identifying parameters such as to minimize the sum of squares
error for each data set.
Fluorescence assays were conducted using strains AML248
through AML261. Three biological replicates were grown in drop
out media lacking uracil and leucine and allowed to grow to early
exponential phase, and prepared as previously described above.
Fluorescent expression profiles were determined using a FACS
Fortessa and compared to a control population. Forward
scattering had a voltage setting of 209 and ampgain of 1.00, side
scattering a voltage of 209 and ampgain of 1.00 and fluorescence a
voltage of 308 and ampgain of 1.00. Forward and side scattering
data were linear and fluorescence was collected on a logarithmic
scale. Threshold was set to a forward scattering value of 5000 with
an OrOperator and area scaling of 0.71.
Yeast Immunofluorescence
Global histone acetylation at H3K18 was measured using yeast
immunofluorescence. Strains AML32, 34, 39, 227, 228, 242–247,
262 were grown to mid-exponential phase and fixed by adding a
10
th volume of 37% formaldehyde for 2 hours. Cells were washed
twice with PBS and resuspended in 500 ml of a spheroplasting
buffer (1.2 M sorbitol and 0.1 M KH2PO4 at pH of 7.5). Cells
were stored for 1–2 days at 4uC. Spheroplasts were made by
incubating 200 ml of fixed cells with 1.2 ml of zymolase (Zymo
Research) and 3.2 mlo fb-mercaptoethanol for 30 minutes at
30uC. Spheroplasts were washed once with 1 mL of PBS+0.05%
Tween 20 and resuspended in 100 ml of PBS+0.05% Tween 20.
Slides were treated with 50 ml of 1 mg/mL poly-L-lysine
(.400,000 MW) for 15 minutes, followed by 3 water washes.
After the slides were completely dry, 20 mL of spheroplasts were
added to each well for 5 minutes, followed by 3 PBS washes. The
slide was immersed in ice cold methanol for 5 minutes and ice cold
acetone for 30 seconds. After drying, the slide was rehydrated by
adding 50 ml of PBS for 5 minutes, followed by a PBS wash. A
blocking solution composed of PBS and 1 mg/mL BSA was added
(20 mL) to each slide followed by 30 minutes in a humid chamber.
The slide was then washed 3 times with PBS. 20 ml of H3K18ac
primary Rabbit antibody (Abcam) diluted 500-fold in blocking
solution was added to each slide and incubated for 90 minutes.
The slide was washed 3 times with PBS. 20 ml of anti-Rabbit Goat
IgG DyLight 649 secondary antibody (Abcam) diluted 200-fold in
blocking solution was added to each slide and incubated for
90 minutes in the dark. The slide was washed 3 times with PBS.
20 mlo f1 mg/mL DAPI in PBS was added to each well for
5 minutes, followed by 3 washes with PBS. A drop of fluorescent
mounting medium (KPL) was added to each slide along with cover
glass (#1.5 thickness) before sealing with nail polish. Slides were
imaged using the Zeiss Axiovert instrument and a 1006
magnifying lens. The DAPI and Cy5 filters were used respectively
to image DAPI and DyLight 649 staining. Average intensity per
cell was determined using Metamorph software.
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Additional variants of a weak TEF promoter (TEFpmut7) [32]
were generated via error-prone PCR using the Genemorph II
Random Mutagenesis Kit from Stratagene and primers 33 and 34.
Six reactions containing differing template concentrations were
combined to create 2 libraries of differing error rates (Table S7).
Libraries were cleaned using the QIAquick PCR Purification Kit
and cut with SacI and XbaI restriction enzymes (New England
Biolabs). Fragments were ligated into a yeast expression vector
upstream of the yECitrine fluorescent gene. 150 ng of each
ligation was transformed into competent E. coli and plated onto LB
agar plates containing 100 mg/mL ampicillin. For each library,
approximately 17,500 colonies were scraped and collected in
liquid culture and diluted to an optical density of 6 using LB
media, and plasmid DNA was extracted using a Qiagen miniprep
kit. From each plasmid library, 50 ng DNA was transformed [52]
into S. cerevisiae BY4741 and plated on drop out media deficient in
uracil.
110 yeast colonies were isolated from the libraries and grown in
minimal media deficient in uracil to an optical density of 0.5 and
analyzed by FACS Calibur, compared to a control strain. Mutants
displaying fluorescence between 30% and 2% of the control
population and low cell-to-cell variability were isolated, and
plasmid DNA was extracted using the Zymoprep Yeast Plasmid
Miniprep I. These plasmids were then sequenced (primers 35 and
36, Fig. S6), and retransformed into yeast to confirm promoter
strength. The selected promoters (Tef32, 51 and 77) have strengths
of 0.1060.01, 0.1560.01, and 0.2260.02 relative to a native TEF
promoter.
Real Time PCR
Relative transcription levels were quantified using real time
PCR from whole cell RNA extracts. Cell lines were grown in
minimal media (M-gYG418) with a starting optical density
between 0.004 and 0.005 until they reached a density between
0.4 and 0.5, at which point whole cell RNA was extracted using
Ambion’s Ribo-Pure kit for yeast. RNA quantification was
performed with a Nanodrop 2000.
The S288C cell lines used for the analysis of HIS3 mRNA levels
were grown in media supplemented with 3.75 mM 3-aminotria-
zole. In addition to the control plasmid (not containing the gcn5-
F221A), promoter strengths of .07, .32, .68 and .95 were tested
(AML31, 32, 34 and 39). cDNA synthesis and quantitative PCR
were performed simultaneously using the iScriptTM One-Step
RT-PCR Kit with SYBR Green (Bio-Rad). We followed the
manufacturer’s instructions, with the following modifications:
100 ng of whole cell RNA per 25 mL reaction, an extended,
15 minute reverse transcription time, and a 56uC annealing
temperature. For the analysis of yECitrine mRNA levels, BY4741
p415-pPho5-yECitrine, p416-TEFmutant-gcn5-F221A cell lines
were grown in minimal media. In addition to the control strain
(no gcn5-F221A), promoter strengths of .07, .16, .32 and .68
percent were tested (AML41, 42, 46 and 49). We determined
relative RNA concentration by comparing the cycle thresholds to
ALG9, which has shown to be an ideal housekeeping gene for yeast
[53]. Primers 19 and 20 were used to amplify HIS3, whereas 21
and 22 were used for ALG9. Primers 22 and 23 were used to
amplify yECitrine.
Real-time PCR confirmation of microarray findings was
conducted on a small scale using whole cell RNA taken from
S288C cell lines grown in minimal media (Fig. S3). In addition to
the control plasmid (no gcn5-F221A) and a gcn5 null strain, a range
of promoter strengths were tested (AML31 through 40 Table S7).
cDNA synthesis was performed using Invitrogen’s High Capacity
cDNA reverse synthesis kit. For quantitative PCR, we used
Roche’s SYBR Green Master Mix, following the manufacturer’s
instructions with an annealing temperature of 58uC. We
concentrated on four gene targets; TKL2, SPL2, IDH2 and
ZRT1. Primers 25 and 26 were used for TKL2, 27 and 28 for
SPL2, 29 and 30 for ZRT1, and 31 and 32 for IDH2. Additionally,
GCN5 mRNA levels were measured with primers 37 and 38, and
mRNA extracted from AML31, 32, 34, 35 and 39.
Gene Expression Microarrays
Global mRNA analysis was conducted using whole cell RNA
taken from S288C cell lines grown in minimal media. In addition
to the control plasmid (no gcn5-F221A) and a gcn5 null strain,
mutant promoter strength 0.32, 0.68 and 0.95 were tested. Cell
lines were grown in biological triplicate with a starting optical
density of 0.0045 and harvested at a density between 0.4 and 0.5.
Whole cell RNA was extracted using the Ambion Ribo-Pure kit for
yeast. cRNA synthesis and fragmentation was conducted by the
Genome Sequencing and Analysis Facility at the University of
Texas using the Ambion MessageAmp Premier kit. Hybridization
and scanning was performed by Asuragen in Austin, TX using
Affymetrix Yeast 2.0 arrays. Data pre-processing and normaliza-
tion was performed using the Robust Multichip Average algorithm
[54,55,56] and Bioconductor’s Affy package. Differentially
expressed genes were identified using the Linear Models for
Microarray Data (LIMMA) package, which resulted in 529 probe
sets. Probe sets were matched with S. cerevisiae genes using
information included in Affymetrix’s Expression Console Soft-
ware, resulting in 504 unique genes. The log2 expression data for
differentially expressed probe sets are reported in Table S1 and
were deposited to Gene Expression Omnibus under accession
number GSE26923.
Measurements of mutant Gcn5p expression levels
RT-PCR was conducted using whole cell RNA extracted from
S288C to determine the level of mutant Gcn5p expression relative
to native Gcn5p. Two control strains, wild-type S288C and S288C
gcn5D carried empty vectors. Additionally, S288C with gcn5-F221A
expressed from varying promoter strengths (.07, .32, .68, .95, and
1.17) were used. Primers were designed such that both wild-type
and mutant GCN5 would be detected. This experiment was carried
out as previously described, and average Ct values were
normalized with respect to the wild-type sample. Since the
sequences are similar between the wild-type and mutant, it was
necessary to deduce the expression level. Specifically, we found
above that ectopic expression of gcn5-F221A does not influence the
expression of GCN5 (Fig. S4). Therefore, net changes in the
amount of GCN5/gcn5-F221A total expression as measured by RT-
PCR must be due to changes in the expression of gcn5-F221A. This
data is shown in Fig. S2.
Growth Analysis for Synthetic Lethal Genes
The impact of the gcn5 dominant mutant on synthetic lethal
genes was assessed using a growth based assay and 22 BY4741
gene knockout strains. As a point of comparison, ten randomly
selected, BY4741 null strains served as a control group, and were
treated under the same conditions. Synthetic lethals were selected
from yGcn5 interaction data, available on yeastgenome.org.
Strains AML67 through AML226 (with biological triplicates) were
grown in minimal media for 2 days prior to inoculating a honey-
comb plate with a starting OD of 0.1. Minimal media lacking
uracil was used. Optical density was measured using a Bioscreen
C, as previously described. An average growth rate and standard
deviation were calculated from the biological replicates. Values
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Supporting Information
Figure S1 GCN5 complementation assay to determine
potential dominant mutants. Using a BY4741 gcn5D strain,
we expressed two Gcn5p mutants (gcn5-M193A and F221A) and
wild-type GCN5 with varying promoter strengths. Strains were
grown in minimal media and growth rate was measured using a
Bioscreen C. We compared the mutant growth rates to that of the
native yeast. Gcn5-M193A was fully functional and no difference in
growth rate was observed. However, the gcn5-F221A mutant
showed no complementation, regardless of promoter strength,
making it a good candidate for a dominant mutant. This process
was repeated with an S288C gcn5D strain, in which we expressed
two Gcn5p mutants (gcn5-M193A and E173A) with varying
promoter strengths. Again, gcn5-M193A was fully functional but
gcn5-E173A is unable to complement the knockout condition,
indicating this mutation interrupts catalytic activity.
(TIF)
Figure S2 At high promoter strengths, mutant Gcn5p
mRNA expression is 8 to 10 times native Gcn5p mRNA
levels. Wild-type and mutant GCN5 mRNA levels were measured
using RT-PCR and whole cell mRNA extracted from S288C wild-
type, gcn5D and gcn5-F221A (with 5 different promoter strengths)
strains. Average Ct values and standard deviation were calculated
from triplicates, and mRNA levels were normalized relative to the
wild-type sample. At the lowest promoter strength of .07, mutant
gcn5-F221A is expressed at levels 2.5 fold higher than wild-type,
and at the highest promoter levels of .95 and 1.17, gcn5-F221A is
expressed at levels 8–10 fold higher than wild-type GCN5.
(TIFF)
Figure S3 RT-PCR of select graded genes confirms
microarray findings. As a follow-up to the gcn5-F221A
microarray study, 4 graded genes (TKL2, SPL2, ZRT1, IDH2)
were selected for higher resolution RT-PCR analysis. RNA was
extracted from S288C wild-type cells (m), S288C Dgcn5 (&),
S288C Dgcn5 with p416-TEF5-GCN5 (X), and S288C with p416-
TEFx-gcn5 F221A (#). Real-time PCR was performed as
previously described using primers 25 to 32 for TKL2, SPL2,
ZRT1 and IDH2 respectively. Based on the microarray study,
TKL2 was categorized as graded and up-regulated by the
dominant mutant with Dgcn5 displaying false negative behavior.
Both trends are reflected in the real time PCR data for TKL2.
SPL2, ZRT1 and IDH2 were all categorized as graded and down-
regulated by the dominant mutant from the microarray data.
Additionally, Dgcn5 displayed opposite behavior for ZRT1. These
behaviors are again reflected in the real time PCR data for these
three genes. Furthermore, ZRT1 and IDH2 show significant
gradation at a much higher promoter strength compared to TKL2
and SPL2. This indicates that TKL2 and SPL2 are more tightly
regulated by Gcn5p.
(TIFF)
Figure S4 Expression of gcn5-F221A does not influence
expression at the native GCN5 promoter. We sought to
determine what, if any, impact, varying expression of mutant
Gcn5p had on the expression of native Gcn5p. A p415-pGcn5-
yECitrine plasmid, with both a short (N) and long (D) GCN5
promoter, is co-expressed with the p416-TEFx-gcn5-F221A plas-
mid collection. In this system, fluorescent protein expression is
controlled by the GCN5 promoter. Regardless of promoter
strength, we observed no change in fluorescent expression, which
indicates that the p416-TEFx-gcn5-F221A.
(TIFF)
Figure S5 Decreased growth rate of S288C caused by
cycloheximide treatment of S288C is linked with Gcn5p
acetylation activity. Using an S288C wild-type strain express-
ing gcn5-F221A at varying promoter strengths (#), we measured
growth rate in the presence of 0.18 mg/mL cycloheximide. As
mutant expression increased, growth rate decreased and ap-
proached that of the gcn5D strain (&). At low mutant expression
levels, growth rate resembled that of the wild-type strain (m). This
demonstrates that the cellular response to cycloheximide is linked
with Gcn5p acetylation. A similar impact was observed at the
HIS3 locus (Fig. 1), a known Gcn5p gene target.
(TIFF)
Figure S6 Three low strength TEF promoters construct-
ed using error prone PCR. Three low strength TEF
promoters (0.1060.01, 0.1560.01 and 0.2260.02, measured
relative to native TEF promoter) were constructed for this study
using error-prone PCR and a fluorescence based screen. Base pair
mutations compared to the native TEF promoter are shown in
red, underlined text above.
(TIFF)
Figure S7 Global acetylation at H3K18 is attenuated by
expression of mutant gcn5-E173A. Using immunofluores-
cence, H3K18 acetylation was assayed globally for strains
harboring the gcn5-E173 mutant expressed with varying promoter
strengths (0.32, 0.68, and 0.95), along with wild-type and gcn5D
cells. The primary antibody, raised in rabbit, targets H3K18ac,
and the secondary antibody is an anti-rabbit IgG tagged with
DyLight 649. All cells were also stained with DAPI to visualize
nuclear material. Cells were imaged with both a DAPI and Cy5
filter. The gcn5-E173A mutant results in global attenuation of
H3K18 acetylation. Using a high strength promoter, acetylation
levels are very similar to that of the gcn5D strain. Average cell
intensity quantification, using Metamorph software, confirms that
increased gcn5-E173A expression decreased acetylation (average
cell intensity from left to right: 133050, 89607, 48178, 37252,
32128).
(TIF)
Table S1 Differentially Expressed Genes and Charac-
terization from Global Microarray Study. From our global
microarray study, we identified 504 unique genes that were
differentially expressed and statistically significant between sample
sets. Here we have catalogued and characterized each of those
genes and the phenomena we observed with regard to the gcn5-
F221A dominant mutant. Gene IDs were matched from
Affymetrix probe sets as previously described (Methods) and
gene names are listed when available. Log2 expression change is
calculated with respect to the control. Tef3, 11 and 5 promoters
have strengths of 0.32, 0.68 and 0.95 respectively compared to a
native TEF promoter. Catalytically associated genes are denoted
with a ‘CA’, and ‘U’ for up-regulated and ‘D’ for down-regulated
genes. ‘NCA’, ‘FN’, and ‘OPP’ correspond to ‘non-catalytically
associated, ‘false negative’ and opposite respectively. Some genes
are listed in multiple categories. ‘Uncat’ denotes a gene that
cannot be categorized based on the criteria previously outlined.
(XLS)
Table S2 Synthetic lethal gene knockouts are impacted
by gcn5-F221A dominant mutant. Growth rates for twenty-
two gcn5D synthetic lethal gene knockouts were determined under
varying dominant mutant expression levels using a Bioscreen C
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serving as a control group. Average growth rates and standard
deviations were calculated from biological triplicates. While some
of the synthetic lethal strains show a graded response to the gcn5-
F221A mutant, none of the control strains are impacted by the
mutant.
(DOC)
Table S3 Putative GCN5-Dependant Growth Inhibitors
were tested for an impact with GCN5 mutant. Previous
studies have identified the following compounds and concentra-
tions which inhibited growth of a Dgcn5 strain compared to wild-
type yeast. We tested the growth of S288C strains expressing gcn5-
F221A in the presence of these compounds in liquid media, as
described in the Materials and Methods.
(DOC)
Table S4 Host Strains. Both E. coli and S. cerevisiae strains were
used in this study, as outlined in Materials and Methods. Each
strain, its genotype and the source from which we obtained the
strain are listed above.
(XLS)
Table S5 Plasmid Carrying Strains. One hundred seventy-
six strains were used in this study, as outlined in Materials and
Methods. Each strain has been assigned a number (AML1 through
AML262), corresponding to a specific genotype, and plasmid(s)
specific to the strain.
(XLS)
Table S6 Primer sequences. Primers used throughout this
study are listed here.
(DOC)
Table S7 Reaction conditions for error-prone PCR.
Three new low strength mutant TEF promoters were developed
for this study (Fig. S2) using error-prone PCR and a fluorescence
based screen. The error-prone PCR conditions (shown above)
resulted in a mutation rate between 4 and 13.5 per kilobase.
(DOC)
Discussion S1
(DOC)
Discussion S2
(DOC)
Discussion S3
(DOC)
Discussion S4
(DOC)
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